The Medical Journal of Australia
Episode 546: MJA Podcasts 2024 Episode 5: Cancer and heart health: discussing cardiotoxic cancer medications, with Dr Benjamin Daniels and Dr Maria Aslam
Feb 18, 2024
Dr Benjamin Daniels and Dr Maria Aslam discuss the impact of cardiotoxic cancer medications on cardiovascular health, focusing on risks, survivorship, prevalence in Australian patients, and the need for specialized care models. They highlight the importance of addressing heart health in cancer survivorship plans, especially for aging populations.
15:58
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Certain cancer medications pose risks for cardiovascular diseases, necessitating cardio-oncology care models.
- Increased survivorship from cancer highlights elevated risks of adverse cardiovascular events from cardiotoxic medications.
Deep dives
Cardiotoxicity of Cancer Medications
Cancer medications are evolving, becoming more effective but also posing risks for cardiovascular diseases. A variety of drugs like immune checkpoint inhibitors and targeted therapies can lead to adverse cardiovascular effects, some of which may have fatal consequences. Additionally, long-term toxicities such as heart failure or ischemia can manifest years after treatment, impacting patients' well-being and healthcare costs.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
